Synopsis
Domestic markets closed slightly lower last week amid mixed global cues. Shares of Dr Reddy’s, Shilpa Medicare, and Tata Motors will be in focus today due to major developments. GR Infraprojects emerged as the selected bidder for an NHAI project worth Rs 4,263 crore. ETMarkets.com GR Infraprojects emerged as the selected bidder for National Highways Authority of India (NHAI) project worth Rs 4,263 crore.
Domestic markets closed marginally lower last week, reflecting a consolidative tone amid mixed global cues. In today’s trade, shares of Dr Reddy’s, Shilpa Medicare, Voltas, TCS, Tata Motors among others will be in focus due to various news developments.
Zydus Life
Zydus Lifesciences has received final approval from the US Food and Drug Administration (USFDA) to manufacture Eluxadoline Tablets, 75 mg and 100 mg.
Galaxy Surfactants
Speciality chemicals manufacturer Galaxy Surfactants it has declared an interim dividend of Rs 18 per equity share.
KEC International
KEC International informed the exchanges that it received an order worth Rs 1,267 crore.
Shilpa Medicare
The US FDA issued a form 483 with 0 observation for Raichur-based unit-2 of its arm Shilpa Pharma Lifesciences.
Brigade Enterprises
Real estate company Brigade Enterprises has launched its latest residential project, Brigade Eternia, in Yelahanka, Bengaluru.
Tata Motors
Tata Motors informed the exchanges that its board will meet on March 19 to consider a fund raising proposal up to Rs 2,000 crore.
TCS
TCS appointed Sudeep Kunnumal as Chief Human Resources Officer Designate effective March 14. He will take over as CHRO upon superannuation of Milind Lakkad.
Voltas
Voltas appointed KV Sridh
Read More